Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
10.0%
1w
21.3%
1m
14.7%
3m
4.4%
6m
5.7%
1y
61.7%
5y
33.0%
all
26.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 11.3 10.0%
8.65
12.3
Company Overview

Sales
95.3 Cr
Growth: 2.5%
Profit after Tax
-44.4 Cr
Growth: 7.3%
Micro Cap
56.8 Cr
P/S: 0.6x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 95.3
Growth 2.5%
EBITDA -0.3%
P/S 0.6x
Dividend 0.0%
P/E -1.6x
Book Value ₹ 9.45
PEG Ratio -0.6x
ROE -67.1%
P/B 1.2x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)